Open original FDA record ↗Recall record
- FDA identifier
- Z-0764-2021
- Company in FDA record
- Becton Dickinson & Co.
- FDA record creation date
- Dec 31, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
BD Phoenix Sulfamethoxazole-trimethoprim (SXT) Resistance, false resistant SXT result with S. aureus could lead to a potential loss of access to a preferred antibiotic regimen and potential reduction in effectiveness of treatment of the infection
Source facts
- Action
- BD issued letters Urgent Medical Device Correction mailed beginning December 8, 2020 with FedEx tracking. Letter states reason for recall, health risk and action to take: 1.Share this product correction notification with all BD Phoenix" users within your facility network and post a copy near all BD Phoenix" instruments until the revised User Manual is available. 2. Respond to the product correction notification electronically by using the link BD.com/IDS-21-3976 or by returning to the attached Customer Response Form to the BD contact noted on the form so that BD may acknowledge your receipt of this notification per FDA requirements. Report any adverse health consequences experienced with the use of this product to BD. Technical Support 800-638-8663 Monday Friday between 7:00am and 7:00pm (EST) in the United States. For customers outside of the United States, contact your local BD representative or distributor Actions Taken by BD: BD is updating the BD Phoenix" User Manual to provide additional guidance on use of the impacted panels and the manual is scheduled to be released by April 30, 2021. The revised manual will be accessible at bd.com/e-labeling. A BDXpert rule is also being developed to further assist customers on how to proceed with MIC readings for SXT. The BDXpert rule is set to be released by March 30, 2021 and will be included in the PUD update
- Initiated
- 2020-12-08
- Root cause
- Nonconforming Material/Component
- Terminated
- 2023-10-03
- Distribution
- Nationwide
- Recall number
- Z-0764-2021
- Recall status
- Terminated
- CDRH record ID
- 184934
- FDA record created
- 2020-12-31
- Recall event number
- 86963